View of Exploring the Efficacy of Triple Therapy with SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Mineralocorticoid Receptor Antagonists on Cardiovascular and Renal Outcomes in Advanced Heart Failure: A Meta-analysis

Return to Article Details Exploring the Efficacy of Triple Therapy with SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Mineralocorticoid Receptor Antagonists on Cardiovascular and Renal Outcomes in Advanced Heart Failure: A Meta-analysis Download Download PDF